Skip to main navigation MRIDIAN CLINICAL COMPANY CONTACT LOGIN GLOBAL SITES Investor Relations Company Overview Financial News Financial Events & Webinars Stock Quote & Chart Historical Price Lookup Analyst Coverage SEC Filings Environmental, Social & Governance (ESG) Management Board of Directors Committee Composition Investor FAQ Contact Investor Relations Whistleblower Hotline COMPANY OVERVIEW ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery. Financial News Date Title and Summary 11/24/21 ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide PDF Version 11/23/21 ViewRay Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in connection with Public Offering of Common Stock PDF Version 11/19/21 ViewRay Announces Closing of Public Offering of Common Stock PDF Version 11/16/21 ViewRay Announces Pricing of Public Offering of Common Stock PDF Version Stock Quote VRAY (Common Stock) Exchange NASDAQ (US Dollar) Price $5.78 Change (%) 0 (0.00%) Volume 0 Data as of 11/24/21 04:00 pm EST Data Provided by Refinitiv. Minimum 15 minutes delayed. Financial Events More events are coming soon. Featured Items Q3 2021 Earnings Presentation Q2 2021 Earnings Presentation Q1 2021 Earnings Presentation 2021 JPM Conference Presentation Q3 2020 Earnings Presentation E-mail Alerts Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now! Click here for E-mail Alerts Transfer Agent American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219 (800) 937-5449 Website: www.amstock.com Email: info@amstock.com In Need of Customer Support? CONTACT Home Safety Privacy Legal MRI-Guided ROAR Discover MRIdian MRIdian Locator Medical Affairs Bibliography About Viewray Newsroom Investors Partner Program Careers Contact ViewRay Headquarters 2 Thermo Fisher Way Oakwood Village, OH 44146 +1 440.703.3210 Phone +1 800.417.3459 Fax West Coast Office 815 E Middlefield Rd Mountain View, CA 94043 +1 650.252.0920 Phone © 2021 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”). ALL RIGHTS RESERVED. INTENDED FOR HEALTHCARE PROFESSIONALS ONLY.